NCT02461849 2022-06-15Patients With Refractory, Metastatic Cancer Harboring KIT Mutation or Amplification to Investigate the Clinical Efficacy and Safety of Imatinib TherapySamsung Medical CenterPhase 2 Unknown14 enrolled
NCT00250042 2011-09-20A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail GleevecNew Mexico Cancer Research AlliancePhase 2 Completed6 enrolled
NCT00180830 2006-09-11Glivec Phase II Pediatric StudyGustave Roussy, Cancer Campus, Grand ParisPhase 2 Terminated36 enrolled